GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Other Income (Expense)

Medexus Pharmaceuticals (FRA:P731) Other Income (Expense) : €-2.01 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Other Income (Expense)?

Medexus Pharmaceuticals's other income expense for the Medexus Pharmaceuticals's pretax income for the three months ended in Sep. 2024 was €-2.27 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-2.01 Mil.

Medexus Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Medexus Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Other Income (Expense) Chart

Medexus Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.03 -18.83 18.87 0.07 0.63

Medexus Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 0.27 0.36 -0.37 -2.27

Medexus Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals  (FRA:P731) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Medexus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Other Income (Expense)
Comparable Companies
TSX:CWEB XCNQ:HUGE TSXV:DB XCNQ:MMEN XCNQ:CXXI TSXV:ZYUS TSX:AVNT XCNQ:ACRG.A.U XCNQ:GDNS TSXV:LSL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MEDXF:USA MDP:Canada
Address
10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
Website
https://www.medexus.com
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Medexus Pharmaceuticals Headlines

No Headlines